Cizzle Biotechnology Holdings PLC (CIZ) - Total Liabilities

Latest as of June 2025: GBX533.00K GBX ≈ $64.85 USD

Based on the latest financial reports, Cizzle Biotechnology Holdings PLC (CIZ) has total liabilities worth GBX533.00K GBX (≈ $64.85 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Cizzle Biotechnology Holdings PLC liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Cizzle Biotechnology Holdings PLC - Total Liabilities Trend (2006–2024)

This chart illustrates how Cizzle Biotechnology Holdings PLC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CIZ current and non-current assets.

Cizzle Biotechnology Holdings PLC Competitors by Total Liabilities

The table below lists competitors of Cizzle Biotechnology Holdings PLC ranked by their total liabilities.

Company	Country	Total Liabilities
The Siam Cement Public Company Limited F:TCM1	Germany	€424.75 Billion
Crimson Tide plc LSE:TIDE	UK	GBX1.29 Million
Mind Gym Ltd LSE:MIND	UK	GBX8.86 Million
Heavitree Brewery A LSE:HVTA	UK	GBX5.16 Million
Novo Integrated Sciences Inc NASDAQ:NVOS	USA	$17.53 Million
Eneraqua Technologies PLC LSE:ETP	UK	GBX23.55 Million
Blackbird PLC LSE:BIRD	UK	GBX677.08K

Liability Composition Analysis (2006–2024)

This chart breaks down Cizzle Biotechnology Holdings PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CIZ net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.93	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	2.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cizzle Biotechnology Holdings PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cizzle Biotechnology Holdings PLC (2006–2024)

The table below shows the annual total liabilities of Cizzle Biotechnology Holdings PLC from 2006 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX410.00K ≈ $49.89	+120.43%
2023-12-31	GBX186.00K ≈ $22.63	+28.28%
2022-12-31	GBX145.00K ≈ $17.64	-33.49%
2021-12-31	GBX218.00K ≈ $26.52	+275.86%
2020-12-31	GBX58.00K ≈ $7.06	+489.07%
2019-12-31	GBX9.85K ≈ $1.20	-97.03%
2018-12-31	GBX331.00K ≈ $40.27	-85.88%
2017-12-31	GBX2.34 Million ≈ $285.20	+1.78%
2016-12-31	GBX2.30 Million ≈ $280.21	-14.32%
2015-12-31	GBX2.69 Million ≈ $327.05	-4.17%
2014-12-31	GBX2.81 Million ≈ $341.29	-10.04%
2013-12-31	GBX3.12 Million ≈ $379.37	-6.84%
2012-12-31	GBX3.35 Million ≈ $407.23	+66.19%
2011-12-31	GBX2.01 Million ≈ $245.05	+31.29%
2010-12-31	GBX1.53 Million ≈ $186.64	+131.02%
2009-12-31	GBX664.00K ≈ $80.79	+15.68%
2008-12-31	GBX574.00K ≈ $69.84	-20.83%
2007-12-31	GBX725.00K ≈ $88.21	-25.18%
2006-12-31	GBX969.00K ≈ $117.90	--

About Cizzle Biotechnology Holdings PLC

LSE:CIZ UK Biotechnology

Market Cap

$77.17K

GBX634.23 Million GBX

Market Cap Rank

#31567 Global

#1157 in UK

Share Price

GBX1.60

Change (1 day)

+6.67%

52-Week Range

GBX1.29 - GBX3.65

All Time High

GBX1144.91